This inventor holds 16 USPTO granted patents. Top assignees: Alfatec-Pharma Gmbh, Paz Arzneimittelentwicklungsgesellschaft Mbh, Alfatec-Pharm Gmbh. Active years: 1993-2002.
Location History:
- Schriesheim, DE (1996 - 2000)
- Wiesloch, DE (1993 - 2002)
Company Filing History:
15 out of 15 
2 out of 7 
1 out of 1 Years Active: 1993-2002
Title: The Innovative Contributions of Ursula Schick in Pharmaceutical Patents
Introduction
Ursula Schick is a prominent inventor based in Schriesheim, Germany, recognized for her significant contributions to the pharmaceutical field. With an impressive portfolio of 16 patents, Schick has focused her research on innovative dosage forms and the improvement of bioavailability for peptide-based medications, particularly insulin.
Latest Patents
Among her latest patented inventions is the "Peroral dosage form for peptide containing medicaments, in particular insulin." This novel approach involves a plural dosage form comprised of a matrix of gelatin or its derivatives, wherein the peptide pharmaceutical, specifically insulin, is distributed along with conventional pharmaceutical carriers and additives. The selection of appropriate gelatin ensures that the pharmaceutical is released in the small or large intestine, thus preventing enzymatic degradation by peptidases.
Another noteworthy patent is related to "Solid bodies containing active substances and a structure consisting of..." This invention details accurately meterable shaped articles, such as granules or pellets, which encapsulate hydrophilic macromolecules and active compounds in a pharmaceutically acceptable matrix. The process of producing these shaped articles is both economically and ecologically favorable, with applications spanning pharmacy, cosmetics, diagnostics, and healthcare, ultimately enhancing bioavailability, shelf life, and tolerability.
Career Highlights
Ursula Schick has worked with several reputable companies in the pharmaceutical industry, including Alfatec-Pharma GmbH and Paz Arzneimittelentwicklungsgesellschaft mbH. Her work has significantly influenced the development of new medication delivery systems and improved therapeutic options for patients.
Collaborations
Throughout her career, Ursula has collaborated with esteemed professionals such as Jens-Christian Wunderlich and Jurgen Werry. These partnerships have fostered innovation and helped to drive her research forward in the competitive landscape of pharmaceutical inventions.
Conclusion
Ursula Schick's contributions to the field of pharmaceuticals through her inventions and patents highlight her as a key figure in the development of more effective medication delivery systems. Her work not only reflects her dedication to improving healthcare but also paves the way for future innovations in the treatment of various medical conditions.